P. 1
DAFTAR PUSTAKA

DAFTAR PUSTAKA

|Views: 3|Likes:

More info:

Published by: Ildzamar Haifa Wardhani on Apr 24, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOCX, PDF, TXT or read online from Scribd
See more
See less

08/30/2015

pdf

text

original

DAFTAR PUSTAKA

1. Organization WH. The World Health Report 1996: Fighting Disease, Fostering Development: the Report of the Director-General: World Health Organization; 1996. 2. Edelman R, Levine MM. Summary of an international workshop on typoid fever. Review of infection disease;1986. 3. The sex and age distribution of the world population. 1996 revision. New Yort: united nation ; 1997 4. WHO/UNICEF Joint monitoring program for water supply and sanitation, Global water supply and sanitation assessment 2000 report. Geneva: WHO/UNICEF;2000 5. Soedarmo, S. P. S., et al. Buku Ajar Infeksi dan Pediatri Tropis,Ik Edisi Kedua :Ikatan Dokter Anak Indonesia;2008 6. Crump JA, Luby SP, Mintz ED. The global burden of typoid fever: Buletin of World Health Organization; 2004 7. Brooks, G.F., Butel, J. S. and Morse, S. A., Jawetz, Melnick & Adelbergh’s: Mikrobiologi Kedokteran. Buku I, Edisi I, Alih bahasa: Bagian Mikrobiologi, Jakarta :FKU Unair, Salemba Medika;2005, 8. Julius, E.S. Mikrobiologi Dasar. Jakarta : Binarupa Aksara Latar; 1990 9. Owen DM, Kulkarni R. Salmonella Infection in Emergency Medicine.2012.[diambil pada tanggal 9 februari 2013]. http://emedicine.medscape.com/article/785774-overview 10. Winn WC, Elmer W, Koneman. Koneman’s Colour Atlas and Textbook of Diagnostic Microbiology.United State of America: Lippincott Williams & Wilkins: 2006. 11. Dzen, SM, dkk. Bakteriologik Medik. Malang: Bayumedia;2003 12. Raffatellu M, Chessa D, Wilson RP, Tükel C, Akçelik M, Bäumler AJ. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun. Jan 2006;74(1):19-27.[Medline]. 13. 6 Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med. Nov 28 2002;347(22):1770-82. [Medline].[Full Text]. 14. Ramsden AE, Mota LJ, Münter S, Shorte SL, Holden DW. The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles. Cell Microbiol. Oct 2007;9(10):2517-29. [Medline] 15. Christie AB. Infectious Diseases: Epidemiology and Clinical Practice. 4th ed. Edinburgh, Scotland: Churchill Livingstone; 1987. 16. Brusch JL, Cunha BA.Typhoid Fever.2012[dikutip http://emedicine.medscape.com/article/231135-overview 2013]: diambil dari:

17. Richard E. Behrman, Robert M. Kliegman, Ann M. Arvin; edisi bahasa Indonesia: A Samik Wahab; Ilmu Kesehatan Anak Nelson, ed.15- Jakarta: EGC;1999. 18. Tumbelaka AR. Diagnosis dan Tata laksana Demam Tifoid. Dalam Pediatrics Update. Cetakan pertama. Jakarta:Ikatan Dokter Anak Indonesia; 2003 19. Rampengan T H. Penyakit infeksi Tropis pada Anak ; edisi 2. Jakarta : EGC; 2007. 20. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ: 2006 21. Todar, K. Salmonella and Salmonellosis. Todar’s Online Textbook of Bacteriology. University of Wisconsin-Madison Department of Bacteriology;2005

Pedoman Imunisasi Di Indonesia. Geneva: WHO. . Makara. Sharma PR. 33. Chloramphenicol in typhoid fever: a review of 110 cases. American Journal of Tropic Medicine Hygine 25. Jakarta:satgas imunisasi Ikatan Dokter Anak Indonesia.Pediatrics in review. Jakarta : Departemen Ilmu Penyakit Dalam FK UI.22. 26.int/entity/vaccine_research/ documents/en/typhoid_diagnosis. Watson KC.4:211-5. Antimikcrob Agents Chemother. edisi IV. satari HI. 1998 27. Tiwari M. Afdhal AF. Pilihan Terapi Empiris Demam Tifoid pada Anak:Kloramfenikol atau seftriakson?. Analisis efektivitas biaya pengobatan demam tifoid anak menggunakan kloramfenikol dan seftriakson di rumah sakit Fatmawati Jakarta tahun 2001-2002. 1995 28 Musnelina L. World Health Organization Department of Vaccines and Biologicals. Sidabutar S. dkk. Engels EA. Harrison CJ. Ho M.pdf.: 2007 23. Ed keempat. Adhikari RK dkk. Moosa A. Gani A. Buku Ajar Ilmu Penyakit Dalam. Treatment of typhoid fever: randomized trial of a three-day course of Ceftriaxone versus a fourteen day course of chloramphenicol. Acharya G. Satari H I. Departemen Ilmu Kesehatan Anak. Kabir I. Buttler T. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Alam NH.2011. Jakarta: Sari Pediatri. (www. Trop Med Int Health 1999. Buttler T. Aru W. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Pediatr Infection Disease Journal 31. Background document: the diagnosis. Rubidge CJ. Pharmacokinetics of ceftriaxone. Klaus SK. Antimicrob. Agents Chemother 1993 30. prevention and treatment of typhoid fever.2010 24. Once daily ceftriaxone vs chloramphenicol for treatment of typhoid fever inchildren. Gasem MH. Dolmans MV. Keuter M. Revoisier C. BRATCHER. Butler T. Cephalosporins A review. Ho M. dkk . 2008. editor . Sudoyo. Jilid III. Lau J. 2003:19-23. Denise.who. RS Dr Cipto Mangunkusumo. ) 32 Van den Bergh ET. Falagas ME. Tiwari M. Paper: Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity:BMJ.Bennish ML. 1998 34. Fakultas Kedokteran Universitas Indonesia. Andayani P. Rampengan TH. 2004 29 Islam A. Acharya G.

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->